1
|
Chróścicka A, Paluch A, Kozera Ł, Lewandowska-Szumieł M. The landscape of biobanks in Poland-characteristics of Polish biobanking units at the beginning of BBMRI.pl organization. J Transl Med 2021; 19:267. [PMID: 34158056 DOI: 10.1186/s12967-021-02926-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/24/2020] [Accepted: 06/04/2021] [Indexed: 12/01/2022] Open
Abstract
Background Biobanking is an area of scientific activity that is growing in strength and importance. The variety of collections combining biological samples and medical scientific information makes biobanking an indispensable tool in the development of modern medicine. In 2016, Poland, a country with one of the largest populations in Europe, joined the Biobanking and BioMolecular resources Research Infrastructure-European Research Infrastructure Consortium (BBMRI-ERIC) to facilitate access to quality-defined human disease-relevant biological resources. This push led to the development of the Polish Biobanking Network. The purpose of this paper is to present the current state of biobanks in Poland in the context of their location, nature and resources. Methods To obtain information about and overall characteristics of Polish entities dealing with biobanking biological material, the dedicated Information Survey was designed. The survey was prepared in an electronic form and consisted of 53 questions—both open and closed, single and multiple choice—with some questions depending on each other. Sixty-five Polish biobanks/biorepositories participated in the survey. Results Polish biobanks are mostly affiliated with research entities (universities—42% and research institutes—30%). The data collected indicate that a considerable number of Polish biobanks are specialized (33 units), in contrast to population-based biobanks (8 units). These biobanks are mostly focused on collecting samples from oncological (23 biobanks) and rare diseases (12 biobanks). In general, great diversity was found in the material collected. Scientists working in Polish biobanks are very open to scientific cooperation (declared by 60% of units) and sharing their collections with the international scientific environment. In terms of quality issues, most biobanks declared that their quality management system was in the process of implementation (45%) or had already been implemented (23%). Conclusions Although biobanking in Poland is still in its infancy, the results of this study seem promising and may be valuable to the wider biobanking research community. The distribution of biobanks throughout the Polish territory, their connection with scientific and clinical units, and their involvement in research on rare diseases may contribute to an increase in the number of multicenter studies.
Collapse
|
2
|
Ferdyn K, Gleńska-Olender J, Witoń M, Zagórska K, Kozera Ł, Chróścicka A, Matera-Witkiewicz A. Quality Management System in the BBMRI.pl Consortium: Status Before the Formation of the Polish Biobanking Network. Biopreserv Biobank 2019; 17:401-409. [PMID: 31009233 DOI: 10.1089/bio.2018.0127] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/14/2023] Open
Abstract
Many types of biomedical research projects depend on high-quality biological material with a data set attached. The Quality Management System (QMS) is focused on operational standards for all organizational activities to ensure that the described quality of each procedure, product, or service is guaranteed. The implementation of the QMS is necessary for the provision of both high quality and repeatability of processes in research laboratories. The current status of implementation of the QMS is determined according to the "Organisation of Polish Biobanking Network" within the project "Biobanking and Biomolecular Resources Research Infrastructure BBMRI-ERIC" supported by the Polish Ministry of Science and Higher Education-decision number DIR/WK/2017/01. According to the above, preliminary audits in six Polish institutions were conducted and reports with recommendations concerning the implementation and improvement of the QMS in Polish biobanks were prepared. During all audits, 13 QMS main areas were analyzed. All audited units belong to the BBMRI.pl consortium, which is responsible for the creation of the Polish Biobanking Network within the BBMRI-ERIC structure. Among all 13 analyzed areas, 27 deviations were identified. Eleven of them were implemented in all audited biobanks but defined as the areas for improvement, 16 of them were not implemented correctly or not implemented at all, respectively (areas underlined to corrective procedures).
Collapse
Affiliation(s)
- Katarzyna Ferdyn
- Screening Laboratory of Biological Activity Test and Collection of Biological Material, Faculty of Pharmacy with Division of Laboratory Diagnostics, Wroclaw Medical University, Wroclaw, Poland.,BBMRI.pl Consortium, PORT, Wroclaw, Poland
| | - Joanna Gleńska-Olender
- Screening Laboratory of Biological Activity Test and Collection of Biological Material, Faculty of Pharmacy with Division of Laboratory Diagnostics, Wroclaw Medical University, Wroclaw, Poland.,BBMRI.pl Consortium, PORT, Wroclaw, Poland
| | - Małgorzata Witoń
- Screening Laboratory of Biological Activity Test and Collection of Biological Material, Faculty of Pharmacy with Division of Laboratory Diagnostics, Wroclaw Medical University, Wroclaw, Poland.,BBMRI.pl Consortium, PORT, Wroclaw, Poland
| | - Karolina Zagórska
- Screening Laboratory of Biological Activity Test and Collection of Biological Material, Faculty of Pharmacy with Division of Laboratory Diagnostics, Wroclaw Medical University, Wroclaw, Poland.,BBMRI.pl Consortium, PORT, Wroclaw, Poland
| | - Łukasz Kozera
- BBMRI.pl Consortium, PORT, Wroclaw, Poland.,PORT, Wroclaw, Poland
| | - Anna Chróścicka
- BBMRI.pl Consortium, PORT, Wroclaw, Poland.,Department of Histology and Embryology, Center for Biostructure Research, Center for Preclinical Research and Technology, Medical University of Warsaw, Warsaw, Poland.,Laboratory for Cell Research and Application, Center for Preclinical Research and Technology, Medical University of Warsaw, Warsaw, Poland
| | - Agnieszka Matera-Witkiewicz
- Screening Laboratory of Biological Activity Test and Collection of Biological Material, Faculty of Pharmacy with Division of Laboratory Diagnostics, Wroclaw Medical University, Wroclaw, Poland.,BBMRI.pl Consortium, PORT, Wroclaw, Poland
| |
Collapse
|